NCT03579121 - Genomic Opioid Optimization of Dosing and Selections (GOODS) Study | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 12, 2018

Primary Completion Date

March 1, 2022

Study Completion Date

April 1, 2022

Conditions

Perioperative/Postoperative Complications

Interventions

OTHER

Pharmacogenomic (PGx)

Administer a pharmacogenomics test (buccal swab) during the pre-operative setting

OTHER

Review results

Pharmacogenomic (PGx) results reviewed by the clinicians during their treatment and the results may guide clinical decisions.

Trial Locations (1)

Mayo Clinic in Arizona, Phoenix